Home - Products - Membrane Transporter/Ion Channel - NMDAR - Aptiganel

Aptiganel

CAS No. 137159-92-3

Aptiganel( —— )

Catalog No. M34164 CAS No. 137159-92-3

Aptiganel (CNS-1102) is a non-competitive NMDA antagonist, a peptide that may be used to study acute ischemic stroke.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	686	In Stock
10MG	938	In Stock
25MG	1444	In Stock
50MG	1841	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Aptiganel
Note

Research use only, not for human use.
Brief Description

Aptiganel (CNS-1102) is a non-competitive NMDA antagonist, a peptide that may be used to study acute ischemic stroke.
Description

Aptiganel (CNS 1102 (free base)), peptide, is a noncompetitive NMDA antagonist with cerebroprotective effects. Aptiganel can be used for the research of stroke.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Membrane Transporter/Ion Channel
Target

NMDAR
Recptor

NMDAR
Research Area

——
Indication

——

Chemical Information

CAS Number

137159-92-3
Formula Weight

303.4
Molecular Formula

C20H21N3
Purity

>98% (HPLC)
Solubility

——
SMILES

N=C(NC1=CC=CC=2C=CC=CC21)N(C3=CC=CC(=C3)CC)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Meadows ME, et al. Delayed treatment with a non-competitive NMDA antagonist, CNS-1102 reduces infarct size in rats. Cerebrovasc Dis.1994;4:26-31.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Glypromate

Glypromate is a neuroprotective agent is a weak NMDA receptor agonist.
Neboglamine hydrochl...

Neboglamine (CR-2249, XY-2401) hydrochloride, an orally active positive modulator of the NMDA receptor glycine site, can be used in schizophrenia research .
Radiprodil

Radiprodil (RGH-896) is an orally active and selective NMDA NR2B receptors antagonist. It was a potential treatment of neuropathic pain associated with diabetic peripheral neuropathy (DPNP).

Sign In Join Free